Tue, Sep 30, 2014, 9:12 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Epizyme, Inc. Message Board

  • rob_cos rob_cos Feb 11, 2014 8:45 PM Flag

    CELG added 340,000 shrs of EPZM ($10 mill) now owns 3.675 million. HUGE POSITIVE

    As I predicted - CELG participated taking 340,000 of the EPZM secondary at $29.25 adding just under $10 million more worth of shares....Now own 3,674,640...hope you bought EPZM dip should head to $40+....


    ...hope you bought EPZM dip should head to $40 imo....CELG stamp of approval – like JMP says best epigenetic play out there…I encouraged buy of dip to $28..predicted $35 but no reason in a good bio market why this doesn't go back to its all time high mid 40s

    SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
    1. Name and Address of Reporting Person* Celgene European Investment Co LLC
    86 MORRIS AVENUE SUMMIT NJ 07901

    2. Issuer Name and Ticker or Trading Symbol
    Epizyme, Inc. [ EPZM

    Common Stock 02/10/2014 P 340,000 A $29.25 3,674,640
    Explanation of Responses:
    1. Of these shares, 3,607,974 are owned directly by Celgene European Investment Company LLC ("CEICO"), a wholly-owned subsidiary of Celgene Corporation ("Celgene"), and Celgene has the power to vote, acquire, hold and dispose of all such shares. Celgene disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. The remaining 66,666 shares are owned directly by Celgene Corporation.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
EPZM
27.11-0.42(-1.53%)Sep 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
eBay Inc.
NasdaqGSTue, Sep 30, 2014 4:15 PM EDT
Cyber-Ark Software Ltd.
NasdaqGSTue, Sep 30, 2014 4:00 PM EDT
BioCryst Pharmaceuticals, Inc.
NasdaqGSTue, Sep 30, 2014 4:15 PM EDT